Resource Library

Rapid Market Assessment in Jordan

Through this rapid assessment, the PSP-One project sought to analyze business conditions and the strategies and practices of the pharmaceutical industry in Jordan. The assessment focused on the private sector, particularly the market potential for generic contraceptive products whose presence on a market can contribute to significantly reducing contraceptive prices. Another area of focus was the willingness of private sector supppliers to increase the range of products available in Jordan and participate in market-building efforts.

Jordan’s high entry barriers and price control limit access to both product innovation and low-cost generic contraceptives. Multinational companies selling contraceptives in Jordan cite high marketing costs and low price ceilings as disincentives for introducing new brands or investing in this market. Asian generic producers are subject to cumbersome and costly procedures that limit their presence in Jordan. Local manufacturers reportedly have no interest in producing contraceptives because their export potential is extremely limited. As a result, generic products are relatively absent from the Jordanian market, which contributes to keeping drug prices high across most therapeutic areas.